States / U.S. Congress / HRES 928

HRES 928 In Committee

Affirming support for most-favored-Nation drug pricing for United States patients.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Introduced in House Dec 4, 2025 · 608 words Open full page ↗

IV

119TH CONGRESS

1ST SESSION

H. RES. 928

Affirming support for most-favored-Nation drug pricing for United States

patients.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.